Thoughtful Investing to Advance Biopharmaceutical Innovation

Avoro Capital is a global life sciences investment firm with a focus on supporting emerging biotechnology companies.


Avoro, by definition, represents our core philosophy around “the support of progress”. The biotechnology sector is undergoing a period of unprecedented transformation. The vast need to efficiently address various diseases and to advance novel therapies to remediate unmet medical needs continues to drive innovative approaches by regulators, large pharma and entrepreneurial firms. This activity fosters an environment where large pharma firms are proactively seeking growth opportunities via partnerships and M&A, rendering assets with differentiating characteristics highly valuable.